BioTech

Biotech stocks to watch ahead of liver disease conference

The number of patients with this chronic liver disease, which can lead to permanent liver scarring, eclipses that of hepatitis C in the U.S., RBC’s Yee said. While a significant number aren’t diagnosed, “we believe, based on survey work, that there are hundreds of thousands of patients with diagnosed NASH,” and that the global market for NASH drugs may reach […]

2 Biotech Stocks to Buy After Earnings

By Louis Navellier, Editor, Blue Chip GrowthTwo of my favorite biotech companies reported third-quarter results today, and they did not disappoint. If you haven’t already picked them up, both of these stocks are solid “buys” at current prices.PLUS: 3 American Financial Stocks to BuyLet’s take a look…Actavis (ACT)Actavis (ACT) surpassed analysts’ sales and earnings expectations for the third quarter. Actavis reported […]

2 Biotech Stocks to Buy After Earnings | InvestorPlace

Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.Copyright ©2014 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.

Original link: 

2 Biotech Stocks to Buy After Earnings | InvestorPlace
 […]

3 Biotech Stocks for Earnings Beats this Season – Earnings ESP

3 Biotech Stocks for Earnings Beats this SeasonEven a quarter back, tax inversion deals were quite a rage among most of the U.S. based biotech firms. However, these tax dodging strategies have fallen apart ever since the U.S. Department of Treasury issued a notice related to tax inversion deals. We have seen AbbVie Inc. ( ABBV ) calling off its […]

Biotech Stock Roundup: Regeneron's Eylea Stumbles, Geron Up on …

Last week, earnings remained in focus with several companies reporting their third quarter results. While AbbVie’s (ABBV – Analyst Report) results remained strong with the company raising its outlook, companies like Regeneron (REGN – Analyst Report) and Aegerion (AEGR – Analyst Report) narrowed their sales outlooks for their key products.Among all this, Geron (GERN – Analyst Report) made it to […]

Buy These Top Ranked ETFs on Solid Biotech Stock Earnings – ETF News And Commentary

Biotech stocks and the related ETFs have been the star performers this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition activities, expansion into emerging markets and ever-increasing health care spending led the sector to easily outperform the broader U.S. equity markets.Though lofty valuations and regulatory concerns did bring in some pain […]

Buy These Top Ranked ETFs on Solid Biotech Stock Earnings …

Biotech stocks and the related ETFs have been the star performers this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition activities, expansion into emerging markets and ever-increasing health care spending led the sector to easily outperform the broader U.S. equity markets.Though lofty valuations and regulatory concerns did bring in some pain […]

Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene …

It was all about earnings last week with several biotech companies reporting third quarter results. While it was a “beat and raise” quarter for quite a few companies, some companies narrowed their outlooks for the year.Recap of the Week’s Most Important Stories1. Companies like Celgene (CELG – Analyst Report), Biogen (BIIB – Analyst Report), Alexion (ALXN – Analyst Report), Cubist […]

Biotech Stock Roundup – Zacks Investment Research

It was all about earnings last week with several biotech companies reporting third quarter results. While it was a “beat and raise” quarter for quite a few companies, some companies narrowed their outlooks for the year.Recap of the Week’s Most Important Stories1. Companies like Celgene (CELG – Analyst Report), Biogen (BIIB – Analyst Report), Alexion (ALXN – Analyst Report), Cubist […]